(
194
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
A New Age in the Management of Pediatric Atopic Dermatitis: Evolution of Disease Understanding and Treatment Opportunities
-
A novel dual key solution to unlock the treatment of allergic rhinitis
-
Activated phosphoinositide 3-kinase δ syndrome (APDS): Challenges in diagnosis, management and recent advances in treatment
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
CRSwNP, a Type 2 Inflammatory disease: Changing treatment paradigm
-
Exploring new horizons: The future of Hereditary Angioedema treatment
-
Path to improving patient care in hereditary angioedema (HAE): what are the treatment goals and how can they be achieved?
-
Raising paediatric awareness through growing evidence for allergy immunotherapy – optimise the treatment of children suffering from respiratory allergy
-
Severe type 2 asthma: phenotypes and precision treatment for patients
-
Closing Gaps in HAE Management: Addressing Treatment Delays in On-Demand Treatment
-
The Evolving Evidence for the Long-Term, Prophylactic Treatment of Hereditary Angioedema Patients with Subcutaneous C1-INH
Show more Sponsored Symposia (9)Show Less-
-
Active treatment of food allergy: time for a change?
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Biological severe asthma treatment in Poland – pros and cons of drug programme
-
Disease burden and treatment of moderate-to-severe atopic dermatitis (AD) in children aged <12 years: results from 732 patients in the PEDISTAD observational study
-
Endotype-driven treatment in chronic rhinosinusitis
-
Endotyping chronic rhinosinusitis for a better treatment approach
-
Flash talks on asthma treatment
-
Introduction – why bacterial lysates in the treatment of allergic diseases? / Wprowadzenie – dlaczego lizaty bakteryjne w terapii schorzen alergicznych ?
-
Novel treatment approaches in urticaria
-
Ophthalmic manifestations of COVID-19 and how it affected ocular allergy treatment
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
Show more Event Resources (9)Show Less-
-
How EAACI recommendations on ocular allergy diagnosis and treatment are applied in real life clinical practice: an international multidisciplinary survey
-
Principles for targeting eicosanoids in the treatment of asthma and allergic diseases
-
Updated treatment of N-ERD: Aspirin desensitization versus Biologics: Evidence-based recommendations: To whom, When, How
-
Alpine Altitude Climate Treatment (previously High Altitude Climate Treatment HACT)
Show more Task Forces (2)Show Less-
-
A systematic review and meta-analysis on nutritional and dietary interventions for the treatment of acute respiratory infection in pediatric patients: An EAACI taskforce
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatment
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper
-
Influenza burden, prevention, and treatment in asthma – A scoping review by the EAACI Influenza in asthma task force
Show more Position Papers (2)Show Less-
Website
Collapse
-
A Semi-Quantitative Evaluation of Leniolisib Treatment Response Through a Physician Survey of Patients with Activated PI3Kδ Syndrome (APDS) Under an Early Access Programme (EAP)
-
A Study Conducted in the Environmental Exposure Chamber (EEC) to Assess Onset of Action of Combination of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Dymista) in the Treatment of Allergic Rhinitis Symptoms Compared to Placebo
-
A comparative dose-response study of prophylactic peanut allergy SLIT and EPIT in Brown Norway rats
-
A possible integrated mind-body approach to CSU treatment
-
Abatacept (cytotoxic T lymphocyte antigen 4-fragment crystallizable) treatment suppressed disease activity in a mouse model of Eosinophilic CRS
-
Advances in Chronic Urticaria treatment
-
Advances in LTP allergy: mechanisms, diagnosis, and treatment
-
Aging and hereditary angioedema: use of new long-term prophylactic therapies in the geriatric population
-
Algorithm for preventative treatment of viral infections reverses the negative impact of atopic traits on day-care absenteeism of preschool children
-
Anaphylaxis during OIT and its impact on treatment adherence: a monocentric retrospective study
-
Anti IgE for the treatment of chronic urticarial
-
Anxiety Associated with On-Demand Treatment for Hereditary Angioedema Attacks
-
Assessing specific pro-catabolic mediators (SPMs) as Innovative Biomarkers in Allergen Immunotherapy: Monitoring Treatment Efficacy
-
Health Care Situation in the Treatment of Uncontrolled GINA 4/5 Asthma Patients in Germany: 2019 vs. 2022
-
Home-based introduction of egg protein in paediatric IgE-mediated Egg allergy – a review of treatment strategy 2011-2021 at Midland Regional Hospital Portlaoise
-
Association between obesity and repeated epinephrine administration for treatment of anaphylaxis: a Taiwan tertiary hospital experience from 2001 to 2020
-
Asthma control, lung function, and quality of life in pediatric patients with severe asthma undergoing biological treatment
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies
-
Balancing HAE and pregnancy: treatment recommendations and approaches
-
Baseline Characteristics of Patients with Severe Asthma in Spain according to biological treatment use: BREATHE study
-
Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease
-
Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease
-
Biomarker-guided approach for treatment of preschool asthma
-
Brazilian Anaphylaxis Registry: Main triggers, clinical manifestations and treatment
-
Challenges in the treatment of CRSwNP with biologics
-
Characterization of Patients With Asthma Initiating Dupilumab Treatment in a Real-World Setting: The RAPID Registry
-
Characterization of patients with Eosinophilic Esophagitis and response to first-line treatment in a Portuguese Immunoallergology Department
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Clinical effects of dupilumab in patients with rhinosinusitis, nasal polyposis, and severe uncontrolled asthma with t2 phenotype, after 12 months of treatment
-
Clinical evaluation of an immunotherapy treatment with Vespa velutina venom in allergic patients. Results from a prospective multicenter Study: W-STING Study
-
Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study
-
Closing Gaps in HAE Management: Addressing Delays in On-Demand Treatment
-
Comparative Gene Expression Analysis in Blood Samples and Nasal Polyps during Dupilumab Treatment for CRSwNP
-
Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children
-
CosMx™ single cell spatial imaging identifies changes in spatial cell communication in chronic rhinosinusitis with nasal polyps following anti – IL-5 treatment
-
Decoding Asthma Therapies: Transcriptomic differences between benralizumab and mepolizumab treatment in patients with severe eosinophilic asthma
-
Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers
-
Demographic Features Of Allergic Rhinitis Patients and Effect of Nasal Corticosteroid Treatment
-
Diagnosis and Treatment of Allergies at ENT Department of General Hospital of Nafplio, Greece
-
Donidalorsen for the treatment of hereditary angioedema: Results from a phase 3, randomised, placebo-controlled trial
-
Dose reduction of dupilumab at 24 months of treatment in patients with controlled atopic dermatitis
-
Dupilumab as effective treatment for chronic pruritus: a case report
-
Dupilumab for Treatment of Eosinophilic Gastrointestinal Disease in children
-
Dupilumab treatment effectively reduces nasal type 2 cytokine production following acetylsalicylic acid provocation in N-ERD patients
-
EAACI & AAAAI Joint Symposium : The Microbiome: A target for treatment and/or prevention of allergic disease
-
Early Responders within One Month of Dupilumab Treatment for Chronic Rhinosinusitis with Nasal Polyps
-
Effect of anti IL-5/IL-5Rα biological treatment on tissue eosinophil subpopulations in patients affected by Chronic Rhinosinusitis with Nasal Polyp
-
Efficacy and Safety of 1-Year Dupilumab Treatment in Children Aged 6-11 years with Moderate-to-Severe Atopic Dermatitis in South Korea: Multicenter Prospective Observational Study
-
Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design
-
Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps
-
Elevating patient treatment outcomes in Severe Asthma
-
Elevating patient treatment outcomes in Severe Asthma & comorbid CRSwNP
-
Emergency treatment of anaphylaxis
-
Empowering Patients: Innovations in Allergic Rhinoconjuntivitis treatment
-
Endotyping chronic rhinosinusitis for a better treatment approach
-
EoE treatment
-
Eosinophilia over dupilumab treatment in asthma patients: a multicentric retrospective study
-
Eosinophilic esophagitis in children and adolescents: clinical, endoscopic, histologic findings, and response to treatment with: fluticasone, budesonide, proton inhibitors and dupilumab
-
Evaluating the Impact of Leniolisib Treatment on Symptoms and Health-Related Quality of Life (HRQoL) in Activated PI3Kδ Syndrome (APDS)
-
Evaluation of patients’ expectation and benefits of sublingual Named-Patient Products in the treatment of allergic respiratory diseases: the French ERAPP prospective cohort study
-
Evolution of health-related quality of life and disease control during the first year of Lanadelumab treatment in Romanian patients with Hereditary Angioedema due to C1-inhibitor deficiency
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
GSK – Elevating patient treatment outcomes in severe asthma and CRSwNP
-
Healthcare Provider Burden associated with the treatment of attacks in patients with hereditary angioedema in Latin America: A Pilot Study
-
Hereditary Angioedema Attack Diary Determination of the Effect of Mobile Application on Patients’ Quality of Life and Treatment Compliance Level
-
How to deal with insufficient response to biologic treatment in CRSwNP
-
How to manage treatment of a red eye
-
ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy
-
Identifying Key Outcomes in the Treatment of Activated PI3K Delta Syndrome: Results From a Modified Delphi Panel
-
Impact of different prophylactic sublingual immunotherapy regimes on peanut allergy prevention in Brown Norway rats
-
Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study
-
Individualized treatment strategy in our unit in patients with predominantly Api m 10 sensitization profile
-
Insights from Benralizumab Treatment
-
International Eczema Council symposium : Safety of JAK inhibitors in the treatment of inflammatory skin diseases
-
Ionis Pharmaceuticals – Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
Long-Term Dupilumab Treatment is Not Associated With an Increased Overall Risk of Infections in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis in an Open-Label Extension Study
-
Long-term safety of donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 open-label extension OASISplus study
-
MY006: anti-allergen multispecific antibody for the treatment of peanut allergy
-
MY010: anti-allergen antibodies for the treatment of Fagales pollen allergy
-
Meta-analysis of primary endpoint of PQ Grass field studies with optimized dose and treatment regimen of PQ Grass
-
Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure
-
Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure
-
Modification of biologic treatment in Super-responders
-
Monitoring for early warning signs of asthma attacks and response to treatment with oral corticosteroids using the Albus Home contactless monitoring system
-
Nasal obstruction in children: diagnosis and treatment
-
New treatment options in childhood atopic dermatitis
-
Novel Treatment Approaches for Patients with SM and Mediator-Related Symptoms
-
Novel treatment approaches in AR: AIT, Biolgicis or the combination?
-
Opening and Introductions: Challenges with Delays in On-demand Treatment
-
Oral Sebetralstat for On-demand Treatment of Hereditary Angioedema: Phase 3 KONFIDENT Trial Results
-
Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach
-
Patient-Reported Benefits of Early On-demand Treatment of HAE Attacks
-
Pectin dietary supplementation as potential treatment of lipid transfer protein allergy
-
Polistes gallicus: an alternative treatment for European paper wasp venom allergic patients?
-
Precision treatment for allergic diseases
-
Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients
-
Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients
-
Predictors of Treatment Response to Biological Therapy in Patients with Severe Asthma: Insights from Induced Sputum Analysis
-
Preimplantation genetic testing in hereditary angioedema: prevention outperforms treatment
-
Prevalence and impact of allergic comorbidities in patients with severe atopic dermatitis in treatment with Dupilumab
-
Psoriasis, allergic rhinitis, biological treatment and immunological therapy – a case report
-
Rationale and Design of the ALPHA-SOLAR Clinical Trial of STAR-0215 for the Treatment of Hereditary Angioedema (HAE)
-
Real-life experience and the safety of Immunobiologicals in the treatment of immunoallergic diseases
-
Real-world efficacy of dupilumab as a second-line treatment in severe asthma- data from a tertiary pulmonary centre
-
Regulatory Perspectives on Food Allergy Treatment and Research
-
Response to benralizumab in severe vernal keratoconjunctivitis after treatment failure with omalizumab
-
Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes
-
Risk stratification in primary care: how to use data to identify people in primary care at risk of harm due to under or over treatment and to prioritise their care
-
Role of The Gut Microbiome in Food Allergy: Potential For Prevention and Treatment
-
SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis
-
Safety and tolerance response of a two day rush protocol treatment in immunotherapy using purified Apis mellifera dry Honeybee venom extract
-
Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment
-
Sanofi : What’s New in CRSwNP? Real-Life Experiences and Current Treatment Goals
-
Sebetralstat as Oral On-demand Treatment for Hereditary Angioedema: Interim Analysis of Demographics and Attack Characteristics from the Open-label KONFIDENT-S Trial
-
Sequence of improvements in objective and patient-reported outcomes with dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: Analysis of the SINUS-52 study
-
Sub-study from the EAACI allergy educational needs in Primary Care Paediatricians to gauge association of GDP impact on differences of allergy diagnosis and treatment healthcare
-
Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe in a pre/co-seasonal treatment regimen – a subgroup comparison
-
Successful Treatment of Post-Orgasmic Illness Syndrome with Omalizumab: A Report on Two Case
-
Successful treatment of lichen amyloidosis with dupilumab treatment: a case report
-
Successful treatment of severe asthma after switch of biologics. A case report
-
Successful treatment of upadacitinib in prurigo nodularis: a case report and review of the literature
-
Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml
-
Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis
-
Systemic Treatment of Atopic Dermatitis in Pregnancy: The Physician’s Perspective
-
Targeted drug-induced apoptosis in key cellular mediators of allergic asthma as a new treatment strategy
-
The Effect of Japanese cedar pollen SLIT-tablets increases with years of treatment
-
The Use of Long-acting Muscarinic Antagonist (LAMA) in the Treatment of Asthma: A Tertiary Asthma Center Experience
-
The autologous serum skin test (ASST) predicts the response to anti-IgE treatment in Chronic Spontaneous Urticaria patients: a prospective study
-
The effect of tezepelumab treatment on the incidence of asthma exacerbations co-occurring with acute respiratory illnesses attributed to infections: results from a pooled analysis of the PATHWAY and NAVIGATOR studies
-
The effectiveness and safety of Abrocitinib treatment for severe atopic dermatitis in the real-world data in Turkey
-
The efficacy in treatment of facial melasma combined with thulium 1927-nm fractional laser and topical H2R antagonist: a split-face, single-blind study
-
The evolution of HAE: Classification and goals of treatment
-
Toward Optimal disease control: impact of maintenance inhaler therapy and device transition in severe asthma patients undergoing monoclonal antibody treatment
-
Treatment of Chronic Spontaneous Urticaria with Omalizumab Complicated by Onychodystrophy?
-
Treatment of Chronic Spontaneous Urticaria with Omalizumab during Pregnancy- Experience in a Portuguese Ucare
-
Treatment of HAE Attacks with Anticipated Future Oral On-demand Therapies as Reported by Patients
-
Treatment of atopic dermatitis patients with dupilumab restores functional responses of circulating skin-homing CD4+ T and B cells
-
Treatment of refractory urticaria in children
-
Treatment of severe asthma (update)
-
Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre
-
Understanding treatment switching patterns and continuation rates for patients with hereditary angioedema receiving lanadelumab: analysis of real-world data
-
Urticaria in the context of treatment with trimethoprim/sulfamethoxazole due to trimethoprim sensitization
-
Weighing the Pros and Cons of systemic steroids in CRS treatment
-
What is the optimal time for diagnosis and treatment of peanut allergy in children?
-
What’s new in CRSwNP? Real-Life experiences and current treatment goals
-
Аnti-inflammatory effect of extracorporeal shock wave therapy as treatment for chronic calculous prostatitis
-
A Phase 3 Open-Label Trial-In-Progress Evaluating Garadacimab For Prophylactic Treatment Of Pediatric Patients (Aged 2–11 Years) With Hereditary Angioedema
-
Investigation Of Treatment Responses And Clinical Characteristics Of Patients With The Late-Onset Asthma Phenotype Under Biological Treatment
-
KalVista Pharmaceuticals – Closing Gaps in HAE Management: Addressing Treatment Delays in On-Demand Treatment
-
Patients with severe eosinophilic asthma starting anti-IL5 treatment after 2018 have better preserved lung function compared to the patients who started treatment earlier
-
Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema
-
Use of the AllergyVax Doctor app to evaluate the correlation between adherence to treatment and control of rhinitis and asthma in patients during treatment with SLIT
-
Self-reported treatment preferences of patients switching from prior prophylactic therapies to donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 OASISplus study
Show more Sessions (153)Show Less-